Acceleration Therapeutics' AT-101 Device Shows Promising Use For Treating Asthma.Business Editors/Health/Medical Writers NORTH BAY VILLAGE, Fla.--(BUSINESS WIRE)--June 1, 2004 Acceleration Therapeutics, a Division of Non-Invasive Monitoring Systems, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :NIMU NIMU Non-Iterative Multi-User NIMU National Iron Molders Union ) today announced that new research indicates that its AT-101 device can effectively treat symptoms of asthma. "Periodic Acceleration Via Nitric Oxide nitric oxide or nitrogen monoxide, a colorless gas formed by the combustion of nitrogen and oxygen as given by the reaction: energy + N2 + O2 → 2NO; m.p. −163.6°C;; b.p. −151.8°C;. Release Modifies Antigen-Induced Airway Responses in Sheep" was presented at the American Thoracic Society's 100th International Conference May 21 - 26 in Orlando, Florida The city of Orlando is a major city in central Florida and is the county seat of Orange County, Florida. According to the 2000 census, the city population was 185,951. A 2006 U.S. . The AT-101 is a comfortable platform that moves the body repetitively in a back and forth motion from head to foot. It is listed with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. as a Class I exempt passive exercise device intended as an aid to improve the circulation and joint mobility. Dr. William Abraham William Abraham may refer to:
This study indicated that nitric oxide released by the AT-101 was distributed throughout the body. It is the first to show that nitric oxide suppresses the activity of nuclear factor kappa beta, a gene that directs inflammation in a whole animal preparation. Dr. Marvin Sackner, President of Acceleration Therapeutics, stated: "The benefit of the AT-101 is its potential for treating human asthma safely and effectively. Furthermore, AT-101 treatments might be beneficial in all chronic diseases that have inflammation as their basis. Acceleration Therapeutics, http://www.accelerationtherapeutics.com, is a leading developer of scientifically-advanced medical devices that offer effective non-invasive, drug-free treatments for people suffering from diseases, conditions and injuries that cause limited mobility or impaired circulation. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion